RxDoctor Payments Data

David Wicker, APRN

Family · Little Rock, ARNPI 1306476957

Payments from drug & device makers

$6,623in general payments, 2019–2025

Across 334 payments — averaging $19.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$1K
  • GSK$767
  • Boehringer Ingelheim$473
  • Sanofi$469
  • Electromed, Inc.$448
  • Regeneron Healthcare Solutions, Inc.$371
  • plus $3K from 23 others

What the payments were for

  • Food & beverage$6,43897%
  • Education$1853%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,623 in reported general payments places this provider in the 95th percentile of 2,103 family providers in Arkansas.

See all family providers in Arkansas

Medicare billing

Part B allowed, 2024
$85,749
Medicare patients
450
Services billed
1,799

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter43$44,684
Breo ElliptaFluticasone/Vilanterol53$26,547
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr19$9,568
Stiolto RespimatTiotropium Br/Olodaterol Hcl11$6,426
SymbicortBudesonide/Formoterol Fumarate23$6,172
Arnuity ElliptaFluticasone Furoate15$3,788
DuleraMometasone/Formoterol11$3,527
Albuterol Sulfate HfaAlbuterol Sulfate79$1,978
Montelukast Sodium159$1,271
Ventolin HfaAlbuterol Sulfate14$837
Omeprazole28$378
Zolpidem Tartrate30$355
Doxycycline Hyclate32$284
Pantoprazole Sodium21$209
Zaleplon13$191

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Arnuity Ellipta$767$84,587130 claims
Boehringer IngelheimStiolto Respimat$473$6,42611 claims
AstraZenecaSymbicort$1,000$6,17223 claims
MerckDulera$143$3,52711 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,103 family providers in Arkansas.

Other family in Little Rock

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →